Pyrazoline sulfanilamide C21 steride saponin aglycone derivative containing thiophene skeleton, as well as preparation method and application of derivative
A dihydropyrazole sulfonamide and saponin aglycone technology, which is applied in the field of dihydropyrazole sulfonamide C21 steroidal saponin aglycon derivatives, can solve problems such as easy drug resistance, limited application range, and reduced use range. To achieve the effect of novel structure, low toxicity and short residual effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0043] 4-(5-(2-thiophene)-3-((3aR,4aS,8S,10aS,11S,12S,12aS)-(8,11,12-trihydroxy)-(10a,12a-dimethyl) Preparation of -(1,2-cyclopentyl)-1,10a-b-epoxyn-tetradecyl)-(4,5-dihydropyrazole))benzenesulfonamide (compound 22)
[0044]
[0045] Under stirring at -20°C, add the corresponding intermediate 13 (10.0mmol) and dichloromethane (25mL) obtained in step 4 to a 50mL round bottom flask in turn, and gradually add boron tribromide (5mmol) dropwise to continue the reaction with stirring After 1 h, the reaction flask was transferred to room temperature, and the reaction was continued for 12 h. TLC tracking reaction (developing agent V AcOEt :V 正己烷 =1:2), after the reaction was completed, filtered, the solid was washed with distilled water, and finally dried in vacuo, and the obtained solid was dissolved in absolute ethanol for recrystallization and purification to obtain the crystalline target compound.
[0046] White crystals were obtained with a yield of 43.9%. m.p.194~195℃; 1...
Embodiment 2
[0048] 4-(5-(2-(5-methyl-thiophene))-3-((3aR,4aS,8S,10aS,11S,12S,12aS)-(8,11,12-trihydroxy)-(10a ,12a-Dimethyl)-(1,2-cyclopentyl)-1,10a-b-epoxy n-tetradecyl)-(4,5-dihydropyrazole))benzenesulfonamide ( Compound 23) Preparation
[0049]
[0050] White crystals were obtained with a yield of 43.9%. m.p.198~199℃; 1 H NMR (DMSO-d 6 ,300MHz)δ:8.01(d,J=7.9Hz,2H,ArH),7.73(d,J=7.3Hz,2H,ArH),6.89(s,2H,NH 2 ), 6.80(d, J=6.7Hz, 1H, CH), 6.55(d, J=5.8Hz, 1H, CH), 5.34(s, 2H, OH), 4.55(s, 1H, OH), 3.88( t,J=6.6Hz,1H,CH),3.54(dd,J 1 =4.7,J 2 =4.8Hz,1H,CH),3.44(t,J=8.1Hz,1H,CH),3.34(d,J=6.8Hz,1H,CH),2.79(dd,J 1 =3.7,J 2 =3.4Hz,2H,CH 2 ),2.37(s,3H,CH 3 ), 2.01(t, J=7.1Hz, 1H, CH), 1.85~1.23(m, 15H, CH and CH 2 ),1.14(dd,J 1 =7.2Hz,J 2 =7.1Hz,1H,CH),0.89(s,3H,CH 3 ),0.84(s,3H,CH 3 ).ESI-MS:642.8[M+H] + .Anal.Calcd for C 33 h 43 N 3 o 6 S 2 :C,H,N.
Embodiment 3
[0052] 4-(5-(2-(5-fluoro-thiophene))-3-((3aR,4aS,8S,10aS,11S,12S,12aS)-(8,11,12-trihydroxy)-(10a, 12a-Dimethyl)-(1,2-cyclopentyl)-1,10a-b-epoxy-n-tetradecyl)-(4,5-dihydropyrazole))benzenesulfonamide (compound 24) Preparation
[0053]
[0054] The preparation method is the same as in Example 1. White crystals were obtained with a yield of 56.2%. m.p.218~219℃; 1 H NMR (DMSO-d 6 ,300MHz)δ:8.04(d,J=6.5Hz,2H,ArH),7.70(d,J=7.4Hz,2H,ArH),6.89(s,2H,NH 2 ), 6.46(d, J=6.7Hz, 1H, CH), 5.32(s, 2H, OH), 5.19(t, J=7.3Hz, 1H, CH), 4.35(s, 1H, OH), 3.82( t,J=5.3Hz,1H,CH),3.54(dd,J 1 =4.7,J 2 =4.8Hz,1H,CH),3.44(t,J=8.1Hz,1H,CH),3.34(d,J=6.8Hz,1H,CH),2.79(dd,J 1 =3.7,J 2 =3.4Hz,2H,CH 2 ), 2.01(t, J=7.4Hz, 1H, CH), 1.76~1.13(m, 15H, CH and CH 2 ),1.11(dd,J 1 =6.7Hz,J 2 =7.3Hz,1H,CH),0.89(s,3H,CH 3 ),0.84(s,3H,CH 3 ).ESI-MS:646.8[M+H] + .Anal.Calcd for C 32 h 40 FN 3 o 6 S 2 :C,H,N.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com